Pay in 4 interest-free payments of $7.20 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
By losing weight, it makes being more active and exercising more frequently much easier
Evidence Snapshot What is BPC-157 vs TB-500
Extended follow-up studies help identify potential effects that may not be apparent in shorter clinical trials
December 2025: Emcure Pharmaceuticals launched Poviztra, a semaglutide-based weight-loss therapy, at USD 106 (INR 8,790) per month, becoming the first Indian company to commercialize Novo Nordisks molecule for obesity
Cauterization involves using electrical current to burn away the bleeding site, while sclerosing agents work by irritating tissues and causing blood clotting that can help stop the bleeding during the endoscopy
A Phase 1 Randomized, Double Blind, Placebo Controlled, Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CT-388 in Otherwise Healthy Overweight and Obese Adult Participants and in Obese Patients With Type 2 Diabetes Mellitus [Internet
